• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在大鼠中脉冲式给予人胰岛素的降糖作用的药代动力学-药效学模型研究。

Pharmacokinetic-pharmacodynamic modelling of the hypoglycaemic effect of pulsatile administration of human insulin in rats.

机构信息

Department of Pharmaceutics, Education and Research Center for Pharmaceutical Sciences, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka, 569-1094, Japan.

出版信息

Sci Rep. 2020 Nov 2;10(1):18876. doi: 10.1038/s41598-020-76007-3.

DOI:10.1038/s41598-020-76007-3
PMID:33139788
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7608663/
Abstract

The relationship between the plasma insulin (INS) concentration-time course and plasma glucose concentration-time course during and after pulsatile INS administration to rats was characterized using a pharmacokinetic-pharmacodynamic (PK-PD) model. A total INS dose of 0.5 IU/kg was intravenously injected in 2 to 20 pulses over a 2-h period. Compared with the single bolus administration, the area under the effect-time curve (AUE) increased depending on the number of pulses, and the AUEs for more than four pulses plateaued at a significantly larger value, which was similar to that after the infusion of a total of 0.5 IU/kg of INS over 2 h. No increase in plasma INS concentration occurred after pulsatile administration. Two indirect response models primarily reflecting the receptor-binding process (IR model) or glucose transporter 4 (GLUT4) translocation (GT model) were applied to describe the PK-PD relationship after single intravenous bolus administration of INS. These models could not explain the observed data after pulsatile administration. However, the IR-GT model, which was a combination of the IR and GT models, successfully explained the effects of pulsatile administration and intravenous infusion. These results indicate that the receptor-binding process and GLUT4 translocation are responsible for the change in AUE after pulsatile administration.

摘要

采用药代动力学-药效学(PK-PD)模型研究了大鼠在脉冲式胰岛素给药期间和之后的血浆胰岛素(INS)浓度-时间曲线和血浆葡萄糖浓度-时间曲线之间的关系。在 2 小时内以 2 到 20 个脉冲的方式静脉内注射 0.5 IU/kg 的总 INS 剂量。与单次推注给药相比,随着脉冲数的增加,效应时间曲线下面积(AUE)增加,并且超过 4 个脉冲的 AUE 趋于平稳,并且显著增加到一个更大的值,这与在 2 小时内输注总共 0.5 IU/kg 的 INS 相似。脉冲式给药后,血浆 INS 浓度没有增加。两种主要反映受体结合过程的间接反应模型(IR 模型)或葡萄糖转运蛋白 4(GLUT4)易位(GT 模型)被应用于描述 INS 单次静脉推注后的 PK-PD 关系。这些模型无法解释脉冲式给药后的观察数据。然而,IR-GT 模型(IR 和 GT 模型的组合)成功地解释了脉冲式给药和静脉输注的作用。这些结果表明,受体结合过程和 GLUT4 易位是脉冲式给药后 AUE 变化的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8b/7608663/ccca408e55e3/41598_2020_76007_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8b/7608663/002f2b1c1d0d/41598_2020_76007_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8b/7608663/3f6a4b91e44b/41598_2020_76007_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8b/7608663/3e37ebc40b4b/41598_2020_76007_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8b/7608663/3bbda8af46ce/41598_2020_76007_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8b/7608663/7dbe310802b7/41598_2020_76007_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8b/7608663/1bf67599bfbd/41598_2020_76007_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8b/7608663/55126e591aba/41598_2020_76007_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8b/7608663/ccca408e55e3/41598_2020_76007_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8b/7608663/002f2b1c1d0d/41598_2020_76007_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8b/7608663/3f6a4b91e44b/41598_2020_76007_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8b/7608663/3e37ebc40b4b/41598_2020_76007_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8b/7608663/3bbda8af46ce/41598_2020_76007_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8b/7608663/7dbe310802b7/41598_2020_76007_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8b/7608663/1bf67599bfbd/41598_2020_76007_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8b/7608663/55126e591aba/41598_2020_76007_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb8b/7608663/ccca408e55e3/41598_2020_76007_Fig8_HTML.jpg

相似文献

1
Pharmacokinetic-pharmacodynamic modelling of the hypoglycaemic effect of pulsatile administration of human insulin in rats.在大鼠中脉冲式给予人胰岛素的降糖作用的药代动力学-药效学模型研究。
Sci Rep. 2020 Nov 2;10(1):18876. doi: 10.1038/s41598-020-76007-3.
2
Pharmacokinetic-pharmacodynamic modelling of insulin: comparison of indirect pharmacodynamic response with effect-compartment link models.胰岛素的药代动力学-药效学建模:间接药效学反应与效应室连接模型的比较
J Pharm Pharmacol. 2002 Jun;54(6):791-800. doi: 10.1211/0022357021779131.
3
Pharmacokinetic-pharmacodynamic modelling of human insulin: validity of pharmacological availability as a substitute for extent of bioavailability.人胰岛素的药代动力学-药效学建模:药理可用性作为生物利用度程度替代指标的有效性。
J Pharm Pharmacol. 2001 Sep;53(9):1235-46. doi: 10.1211/0022357011776685.
4
Pharmacokinetic and pharmacodynamic modelling of the effects of glimepiride on insulin secretion and glucose lowering in healthy humans.格列美脲对健康人体胰岛素分泌和降糖作用的药代动力学和药效学建模。
J Clin Pharm Ther. 2006 Oct;31(5):469-76. doi: 10.1111/j.1365-2710.2006.00766.x.
5
Pharmacodynamics and pharmacokinetics of a new type of recombinant insulin Lisargine injection.新型重组胰岛素赖脯氨酸注射液的药效学和药代动力学。
BMC Complement Med Ther. 2020 Nov 9;20(1):334. doi: 10.1186/s12906-020-03110-3.
6
Co-administration of liraglutide with insulin detemir demonstrates additive pharmacodynamic effects with no pharmacokinetic interaction.利拉鲁肽与地特胰岛素联合给药具有相加的药效学作用,无药代动力学相互作用。
Diabetes Obes Metab. 2011 Jan;13(1):75-80. doi: 10.1111/j.1463-1326.2010.01322.x.
7
Population pharmacokinetic-pharmacodynamic modeling of subcutaneous and pulmonary insulin in rats.大鼠皮下和肺部胰岛素的群体药代动力学-药效学建模
J Pharmacokinet Pharmacodyn. 2005 Aug;32(3-4):485-500. doi: 10.1007/s10928-005-0008-4.
8
Pharmacokinetic-pharmacodynamic analysis of the glucose-lowering effect of metformin in diabetic rats reveals first-pass pharmacodynamic effect.二甲双胍对糖尿病大鼠降血糖作用的药代动力学-药效学分析揭示了首过药效学效应。
Drug Metab Dispos. 2002 Aug;30(8):861-8. doi: 10.1124/dmd.30.8.861.
9
Comparison of the priming effects of pulsatile and continuous insulin delivery on insulin action in man.脉冲式与持续胰岛素输注对人体胰岛素作用的启动效应比较。
Metabolism. 2003 Aug;52(8):1050-5. doi: 10.1016/s0026-0495(03)00156-2.
10
Pharmacokinetic-pharmacodynamic (PK-PD) modeling and simulation of 5-fluorouracil for erythropenia in rats.5-氟尿嘧啶对大鼠红细胞减少症的药代动力学-药效学(PK-PD)建模与模拟
J Pharmacol Toxicol Methods. 2014 Sep-Oct;70(2):134-44. doi: 10.1016/j.vascn.2014.07.007. Epub 2014 Jul 26.

引用本文的文献

1
Study on bioequivalence and influence of obesity-related indicators on pharmacokinetics and pharmacodynamics for insulin degludec in healthy subjects.健康受试者中性胰岛素 Degludec 的药代动力学和药效学的生物等效性及肥胖相关指标影响的研究。
Sci Rep. 2024 Oct 21;14(1):24687. doi: 10.1038/s41598-024-75554-3.
2
Fabrication and evaluation of nanoemulsion based insulin loaded microneedles for transdermal drug delivery.用于透皮给药的基于纳米乳液的载胰岛素微针的制备与评价
Ther Deliv. 2024;15(8):605-617. doi: 10.1080/20415990.2024.2377065. Epub 2024 Jul 29.
3
Polyester Nanoparticles with Controlled Topography for Peroral Drug Delivery Using Insulin as a Model Protein.

本文引用的文献

1
A machine-learning approach to predict postprandial hypoglycemia.一种预测餐后低血糖的机器学习方法。
BMC Med Inform Decis Mak. 2019 Nov 6;19(1):210. doi: 10.1186/s12911-019-0943-4.
2
Toward Better Understanding of Insulin Therapy by Translation of a PK-PD Model to Visualize Insulin and Glucose Action Profiles.通过将 PK-PD 模型转化为可视化胰岛素和葡萄糖作用谱,以更好地理解胰岛素治疗。
J Clin Pharmacol. 2019 Feb;59(2):258-270. doi: 10.1002/jcph.1321. Epub 2018 Oct 19.
3
In Silico Modeling of Minimal Effective Insulin Doses Using the UVA/PADOVA Type 1 Diabetes Simulator.
具有受控形貌的聚酯纳米粒子用于经口递药:以胰岛素作为模型蛋白。
ACS Nano. 2024 May 7;18(18):11863-11875. doi: 10.1021/acsnano.4c01027. Epub 2024 Apr 15.
使用UVA/帕多瓦1型糖尿病模拟器对最小有效胰岛素剂量进行计算机模拟建模。
J Diabetes Sci Technol. 2018 Mar;12(2):376-380. doi: 10.1177/1932296817735341. Epub 2017 Sep 27.
4
A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes.1型糖尿病成人持续皮下胰岛素输注(CSII)胰岛素给药公式综述
Curr Diab Rep. 2016 Sep;16(9):83. doi: 10.1007/s11892-016-0772-0.
5
Signaling pathways involved in cardiac energy metabolism.参与心脏能量代谢的信号通路。
FEBS Lett. 2016 Aug;590(15):2364-74. doi: 10.1002/1873-3468.12297. Epub 2016 Jul 23.
6
Influence of dietary protein on postprandial blood glucose levels in individuals with Type 1 diabetes mellitus using intensive insulin therapy.膳食蛋白质对采用强化胰岛素治疗的1型糖尿病患者餐后血糖水平的影响。
Diabet Med. 2016 May;33(5):592-8. doi: 10.1111/dme.13011. Epub 2015 Dec 6.
7
Application of PK/PD modeling and simulation to dosing regimen optimization of high-dose human regular U-500 insulin.药代动力学/药效学(PK/PD)建模与模拟在高剂量人常规U-500胰岛素给药方案优化中的应用。
J Diabetes Sci Technol. 2014 Jul;8(4):821-9. doi: 10.1177/1932296814532326. Epub 2014 May 12.
8
Endocytosis, recycling, and regulated exocytosis of glucose transporter 4.葡萄糖转运蛋白 4 的内吞作用、回收和受调控的胞吐作用。
Biochemistry. 2011 Apr 19;50(15):3048-61. doi: 10.1021/bi2000356. Epub 2011 Mar 25.
9
Pharmacokinetic and pharmacodynamic modeling of exendin-4 in type 2 diabetic Goto-Kakizaki rats.2 型糖尿病 Goto-Kakizaki 大鼠中 exendin-4 的药代动力学和药效学建模。
J Pharmacol Exp Ther. 2011 Mar;336(3):881-90. doi: 10.1124/jpet.110.175752. Epub 2010 Dec 14.
10
Pharmacokinetic/pharmacodynamic modeling of glucose clamp effects of inhaled and subcutaneous insulin in healthy volunteers and diabetic patients.健康志愿者和糖尿病患者吸入和皮下胰岛素的葡萄糖钳夹效应的药代动力学/药效学模型。
Drug Metab Pharmacokinet. 2010;25(5):418-29. doi: 10.2133/dmpk.dmpk-10-rg-017. Epub 2010 Sep 30.